Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature – In a phase 1 trial, personalized mRNA vaccines tailored to individual tumour mutations in triple-negative brea...
#General #Medicine #News #BreastCancer
Origin | Interest | Match
#General #Medicine #News #BreastCancer
Origin | Interest | Match
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Nature – In a phase 1 trial, personalized mRNA vaccines tailored to individual tumour mutations in triple-negative breast cancer induced robust, long-lasting T cell responses and improved prognosis.
Read the full article here
www.mashupmd.com
February 19, 2026 at 3:27 AM
The survey results come as more women are eligible for breast cancer screening due to recently adjusted guidelines #breastcancer #mammography
Survey: Nearly 4 out of 5 practices short on breast imagers
New survey data by Medicus point to staffing shortages of breast radiologists among U.S. practices.
buff.ly
February 18, 2026 at 9:13 PM
The survey results come as more women are eligible for breast cancer screening due to recently adjusted guidelines #breastcancer #mammography
Almost up to 90,000 signatures! Please sign and share if you haven’t already 🙏 #breastcancer #mammogram
Please support and share this important petition, which was started by a chemotherapy nurse in the UK. Thank you 🩷
petition.parliament.uk/petitions/74...
petition.parliament.uk/petitions/74...
Petition: Lower the age for invites to regular mammograms to 40 & perform annually
Lower the age for when you are first called to 40 and provide funding to carry out Mammograms Annually instead of every Three Years
petition.parliament.uk
February 18, 2026 at 8:32 PM
Almost up to 90,000 signatures! Please sign and share if you haven’t already 🙏 #breastcancer #mammogram
Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat #breastcancer @nature.com
www.nature.com/articles/d41... @biontech.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/d41... @biontech.bsky.social
www.nature.com/articles/s41...
February 18, 2026 at 7:16 PM
Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat #breastcancer @nature.com
www.nature.com/articles/d41... @biontech.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/d41... @biontech.bsky.social
www.nature.com/articles/s41...
#Senescence, while required for #postpartum tissue remodeling, can be hijacked to facilitate tumorigenesis, defining senescence as a unifying mechanism linking tissue repair to tumorigenesis @nataging.nature.com #breastcancer
www.nature.com/articles/s43...
www.nature.com/articles/s43...
February 18, 2026 at 4:57 PM
#Senescence, while required for #postpartum tissue remodeling, can be hijacked to facilitate tumorigenesis, defining senescence as a unifying mechanism linking tissue repair to tumorigenesis @nataging.nature.com #breastcancer
www.nature.com/articles/s43...
www.nature.com/articles/s43...
The Red Breasts is a social group for #breastcancer survivors that meets up every month at The Red in Dyserth. Please share & help raise awareness of this fab group of determined women! There is always laughter, chatter & friendly support.
#NorthWales
#cancer
#Wales
#NorthWales
#cancer
#Wales
February 18, 2026 at 4:56 PM
The Red Breasts is a social group for #breastcancer survivors that meets up every month at The Red in Dyserth. Please share & help raise awareness of this fab group of determined women! There is always laughter, chatter & friendly support.
#NorthWales
#cancer
#Wales
#NorthWales
#cancer
#Wales
Senescence links regeneration to oncogenic vulnerability.
Our latest work demonstrates that #senescence drives #postpartum mammary involution while simultaneously creating a transient microenvironment permissive for tumor initiation #breastcancer. @institutpasteur.bsky.social
More details 👇
Our latest work demonstrates that #senescence drives #postpartum mammary involution while simultaneously creating a transient microenvironment permissive for tumor initiation #breastcancer. @institutpasteur.bsky.social
More details 👇
Online now! ✨Chiche, Djoual, Charifou et al identify a dual role for senescence in postpartum tissue remodelling: senescent cells drive mammary gland involution, yet predispose to postpartum tumor initiation @hanli-pasteur.bsky.social @pasteur.fr
Induction of senescence during postpartum mammary gland involution supports tissue remodeling and promotes postpartum tumorigenesis - Nature Aging
Chiche, Djoual, Charifou and colleagues identify a dual role for cell senescence in postpartum tissue remodeling: senescent cells drive mammary gland involution, yet create a permissive niche for tumo...
www.nature.com
February 18, 2026 at 4:47 PM
Senescence links regeneration to oncogenic vulnerability.
Our latest work demonstrates that #senescence drives #postpartum mammary involution while simultaneously creating a transient microenvironment permissive for tumor initiation #breastcancer. @institutpasteur.bsky.social
More details 👇
Our latest work demonstrates that #senescence drives #postpartum mammary involution while simultaneously creating a transient microenvironment permissive for tumor initiation #breastcancer. @institutpasteur.bsky.social
More details 👇
BoobyRogue: Tumor Takedown will be part of Steam Next Fest, running from February 23rd to March 2nd!
Try the demo:
store.steampowered.com/app/4072080?...
#IndieGame #GameDev #ActionRoguelike #Roguelike #BreastCancer #Wishlist #Godot
Try the demo:
store.steampowered.com/app/4072080?...
#IndieGame #GameDev #ActionRoguelike #Roguelike #BreastCancer #Wishlist #Godot
February 18, 2026 at 3:35 PM
BoobyRogue: Tumor Takedown will be part of Steam Next Fest, running from February 23rd to March 2nd!
Try the demo:
store.steampowered.com/app/4072080?...
#IndieGame #GameDev #ActionRoguelike #Roguelike #BreastCancer #Wishlist #Godot
Try the demo:
store.steampowered.com/app/4072080?...
#IndieGame #GameDev #ActionRoguelike #Roguelike #BreastCancer #Wishlist #Godot
Update as of Feb.18
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
February 18, 2026 at 2:45 PM
Update as of Feb.18
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
Scott didn’t plan to binge. One drink after Susan’s appointment… and then the fear hit.
He couldn’t stop thinking: 𝗪𝗵𝘆 𝗵𝗲𝗿?
And the harder question: when it’s time to fight — 𝗪𝗶𝗹𝗹 𝗵𝗲 𝘀𝘁𝗮𝘆?
Chapter 21 of 44 — Hijacked Intelligence
#RomanticSuspense #ebooks #BreastCancer
He couldn’t stop thinking: 𝗪𝗵𝘆 𝗵𝗲𝗿?
And the harder question: when it’s time to fight — 𝗪𝗶𝗹𝗹 𝗵𝗲 𝘀𝘁𝗮𝘆?
Chapter 21 of 44 — Hijacked Intelligence
#RomanticSuspense #ebooks #BreastCancer
February 18, 2026 at 1:35 PM
Scott didn’t plan to binge. One drink after Susan’s appointment… and then the fear hit.
He couldn’t stop thinking: 𝗪𝗵𝘆 𝗵𝗲𝗿?
And the harder question: when it’s time to fight — 𝗪𝗶𝗹𝗹 𝗵𝗲 𝘀𝘁𝗮𝘆?
Chapter 21 of 44 — Hijacked Intelligence
#RomanticSuspense #ebooks #BreastCancer
He couldn’t stop thinking: 𝗪𝗵𝘆 𝗵𝗲𝗿?
And the harder question: when it’s time to fight — 𝗪𝗶𝗹𝗹 𝗵𝗲 𝘀𝘁𝗮𝘆?
Chapter 21 of 44 — Hijacked Intelligence
#RomanticSuspense #ebooks #BreastCancer
Younger age (≤40), late‑line therapy, and prior platinum were linked to shorter PFS.
Toxicities were manageable, with hematologic AEs most common.
This study adds valuable Asian real‑world evidence to guide PARPi use.
#BreastCancer #PARPi #RWE #PrecisionOncology
Toxicities were manageable, with hematologic AEs most common.
This study adds valuable Asian real‑world evidence to guide PARPi use.
#BreastCancer #PARPi #RWE #PrecisionOncology
February 18, 2026 at 8:15 AM
Younger age (≤40), late‑line therapy, and prior platinum were linked to shorter PFS.
Toxicities were manageable, with hematologic AEs most common.
This study adds valuable Asian real‑world evidence to guide PARPi use.
#BreastCancer #PARPi #RWE #PrecisionOncology
Toxicities were manageable, with hematologic AEs most common.
This study adds valuable Asian real‑world evidence to guide PARPi use.
#BreastCancer #PARPi #RWE #PrecisionOncology
A new multicenter Chinese study in Ther Adv Med Onc evaluated PARPi in metastatic #breastcancer with HRR gene pathogenic variants.
mPFS reached 6.0 months, with consistent benefit across BRCA1/2, PALB2 and other HRR mutations.
🔗 buff.ly/x4JnB05
#MBC #PARP #HRR
mPFS reached 6.0 months, with consistent benefit across BRCA1/2, PALB2 and other HRR mutations.
🔗 buff.ly/x4JnB05
#MBC #PARP #HRR
February 18, 2026 at 8:15 AM
A new multicenter Chinese study in Ther Adv Med Onc evaluated PARPi in metastatic #breastcancer with HRR gene pathogenic variants.
mPFS reached 6.0 months, with consistent benefit across BRCA1/2, PALB2 and other HRR mutations.
🔗 buff.ly/x4JnB05
#MBC #PARP #HRR
mPFS reached 6.0 months, with consistent benefit across BRCA1/2, PALB2 and other HRR mutations.
🔗 buff.ly/x4JnB05
#MBC #PARP #HRR
Breast cancer treatment can affect heart health. ❤️🩹
Here’s how doctors monitor for cardiovascular side effects before, during, and after treatment: https://bit.ly/3ZHRsCm
#HeartHealth #HeartMonth #BreastCancer #BreastCancerSurvivor
Here’s how doctors monitor for cardiovascular side effects before, during, and after treatment: https://bit.ly/3ZHRsCm
#HeartHealth #HeartMonth #BreastCancer #BreastCancerSurvivor
February 18, 2026 at 3:22 AM
Breast cancer treatment can affect heart health. ❤️🩹
Here’s how doctors monitor for cardiovascular side effects before, during, and after treatment: https://bit.ly/3ZHRsCm
#HeartHealth #HeartMonth #BreastCancer #BreastCancerSurvivor
Here’s how doctors monitor for cardiovascular side effects before, during, and after treatment: https://bit.ly/3ZHRsCm
#HeartHealth #HeartMonth #BreastCancer #BreastCancerSurvivor
Irish #breastcancer survivor Jennifer Wrynne marks the end of her radiotherapy journey with gratitude and strength, celebrating a major milestone after a challenging treatment path. Resilience in action for the cancer community.
#CancerSurvivor #Inspiration #TCSC
www.thesun.ie/tvandshowbiz...
#CancerSurvivor #Inspiration #TCSC
www.thesun.ie/tvandshowbiz...
Irish star celebrates after last radiotherapy session as she battles cancer
IRISH star Jennifer Wrynne has celebrated after her last radiotherapy session. The Leitrim native was diagnosed with breast cancer in June 2025 at the age of 36, after discovering a lump in her bre…
www.thesun.ie
February 17, 2026 at 10:28 PM
Irish #breastcancer survivor Jennifer Wrynne marks the end of her radiotherapy journey with gratitude and strength, celebrating a major milestone after a challenging treatment path. Resilience in action for the cancer community.
#CancerSurvivor #Inspiration #TCSC
www.thesun.ie/tvandshowbiz...
#CancerSurvivor #Inspiration #TCSC
www.thesun.ie/tvandshowbiz...
A mysterious RNA in breast cancer has led scientists to uncover a hidden class of genetic elements that seem to drive tumour growth, opening up a brand-new layer of targets for future treatments.
www.sciencedaily.com/releases/202...
#BreastCancer #CancerResearch #TCSC
www.sciencedaily.com/releases/202...
#BreastCancer #CancerResearch #TCSC
Mysterious RNA led scientists to a hidden layer of cancer
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across dozens of tumor types. These molecules form unique molecular signatures that ide...
www.sciencedaily.com
February 17, 2026 at 10:25 PM
A mysterious RNA in breast cancer has led scientists to uncover a hidden class of genetic elements that seem to drive tumour growth, opening up a brand-new layer of targets for future treatments.
www.sciencedaily.com/releases/202...
#BreastCancer #CancerResearch #TCSC
www.sciencedaily.com/releases/202...
#BreastCancer #CancerResearch #TCSC
New in JHEOR: A lifetime Markov model showed that adjuvant trastuzumab-emtansine is cost-effective and cost-saving vs trastuzumab for HER2+ breast cancer with residual disease in Colombia. jheor.org/article/156056 #HEOR #breastcancer
February 17, 2026 at 7:30 PM
New in JHEOR: A lifetime Markov model showed that adjuvant trastuzumab-emtansine is cost-effective and cost-saving vs trastuzumab for HER2+ breast cancer with residual disease in Colombia. jheor.org/article/156056 #HEOR #breastcancer
For #CancerPreventionMonth, new data show persistent underscreening for #breastcancer among survivors of other malignancies.
• 75.3% screening rate in survivors vs 77.2% in controls
• Adjusted OR: 0.82
Read the review: ➡️https://bit.ly/46euMx8
#Oncology #PublicHealth #bcsm
• 75.3% screening rate in survivors vs 77.2% in controls
• Adjusted OR: 0.82
Read the review: ➡️https://bit.ly/46euMx8
#Oncology #PublicHealth #bcsm
February 17, 2026 at 5:52 PM
For #CancerPreventionMonth, new data show persistent underscreening for #breastcancer among survivors of other malignancies.
• 75.3% screening rate in survivors vs 77.2% in controls
• Adjusted OR: 0.82
Read the review: ➡️https://bit.ly/46euMx8
#Oncology #PublicHealth #bcsm
• 75.3% screening rate in survivors vs 77.2% in controls
• Adjusted OR: 0.82
Read the review: ➡️https://bit.ly/46euMx8
#Oncology #PublicHealth #bcsm
✅ Free registration
✅ Online
✅ On-demand
Register now and start today! 🔗 https://www.scientificbites.com/?lang=en
#beSOLTI #ScientificBitesSOLTI #breastcancer
✅ Online
✅ On-demand
Register now and start today! 🔗 https://www.scientificbites.com/?lang=en
#beSOLTI #ScientificBitesSOLTI #breastcancer
Scientific Bites – Cancer research e-learning platform
www.scientificbites.com
February 17, 2026 at 4:06 PM
✅ Free registration
✅ Online
✅ On-demand
Register now and start today! 🔗 https://www.scientificbites.com/?lang=en
#beSOLTI #ScientificBitesSOLTI #breastcancer
✅ Online
✅ On-demand
Register now and start today! 🔗 https://www.scientificbites.com/?lang=en
#beSOLTI #ScientificBitesSOLTI #breastcancer
Update as of Feb.17
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
February 17, 2026 at 2:03 PM
Update as of Feb.17
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
Please #share #help #fundraising #breastcancer #chemotherapy #treatment #surgery #repost
Donation Link: ko-fi.com/miqojasky/go...
20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment
www.annalsofoncology.org/article/S092...
20 years after approval, trastuzumab remains the therapeutic backbone for HER2+ early #BreastCancer delivering durable survival benefits across risk groups and chemo regimens
www.annalsofoncology.org/article/S092...
20 years after approval, trastuzumab remains the therapeutic backbone for HER2+ early #BreastCancer delivering durable survival benefits across risk groups and chemo regimens
February 17, 2026 at 1:34 PM
20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment
www.annalsofoncology.org/article/S092...
20 years after approval, trastuzumab remains the therapeutic backbone for HER2+ early #BreastCancer delivering durable survival benefits across risk groups and chemo regimens
www.annalsofoncology.org/article/S092...
20 years after approval, trastuzumab remains the therapeutic backbone for HER2+ early #BreastCancer delivering durable survival benefits across risk groups and chemo regimens
February 24
Online - 5 sessions only
Coordinated by Rodrigo Dienstmann (VHIO) and Guillermo Villacampa (SOLTI, VHIO)
👉 LAST DAYS! Free registration open 🔗 https://www.gruposolti.org/events/rwe-to-support-clinical-decision-making/
#beSOLTI #breastcancer
Online - 5 sessions only
Coordinated by Rodrigo Dienstmann (VHIO) and Guillermo Villacampa (SOLTI, VHIO)
👉 LAST DAYS! Free registration open 🔗 https://www.gruposolti.org/events/rwe-to-support-clinical-decision-making/
#beSOLTI #breastcancer
Unlocking the power of Real-World Evidence to support clinical decision making
This course will focus on critically understanding the clinical utility of real-world evidence (RWE) in breast cancer research. Using examples from cancer research, the course will […]
www.gruposolti.org
February 17, 2026 at 11:04 AM
February 24
Online - 5 sessions only
Coordinated by Rodrigo Dienstmann (VHIO) and Guillermo Villacampa (SOLTI, VHIO)
👉 LAST DAYS! Free registration open 🔗 https://www.gruposolti.org/events/rwe-to-support-clinical-decision-making/
#beSOLTI #breastcancer
Online - 5 sessions only
Coordinated by Rodrigo Dienstmann (VHIO) and Guillermo Villacampa (SOLTI, VHIO)
👉 LAST DAYS! Free registration open 🔗 https://www.gruposolti.org/events/rwe-to-support-clinical-decision-making/
#beSOLTI #breastcancer
The countdown is on ⏳ On April 16, science, AI and oncology meet at SOLTI NEXUS.
If you want to stay ahead, don’t stay out!
Register for free 🔗 https://www.gruposolti.org/events/soltinexus/
#beSOLTI #SOLTINexus #breastcancer
If you want to stay ahead, don’t stay out!
Register for free 🔗 https://www.gruposolti.org/events/soltinexus/
#beSOLTI #SOLTINexus #breastcancer
February 17, 2026 at 9:16 AM
The countdown is on ⏳ On April 16, science, AI and oncology meet at SOLTI NEXUS.
If you want to stay ahead, don’t stay out!
Register for free 🔗 https://www.gruposolti.org/events/soltinexus/
#beSOLTI #SOLTINexus #breastcancer
If you want to stay ahead, don’t stay out!
Register for free 🔗 https://www.gruposolti.org/events/soltinexus/
#beSOLTI #SOLTINexus #breastcancer
Is T-DXd worth it for breast cancer? Cost-effectiveness study: vs T-DM1, adds 1.7 QALYs at $1927/QALY—below Iran's threshold. Supports adoption for HER2+ MBC. #BreastCancer #HealthEconomics www.rimpacts.com/rd/p?c=10041... 📄DOI: doi.org/10.1186/s129...
Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer: Cost-Effectiveness Analysis From Iranian Experience
Is T-DXd worth it for breast cancer? Cost-effectiveness study: vs T-DM1, adds 1.7 QALYs at $1927/QALY—below Iran's threshold. Supports adoption for HER2+ MBC. #BreastCancer #HealthEconomics
www.rimpacts.com
February 17, 2026 at 8:31 AM
Is T-DXd worth it for breast cancer? Cost-effectiveness study: vs T-DM1, adds 1.7 QALYs at $1927/QALY—below Iran's threshold. Supports adoption for HER2+ MBC. #BreastCancer #HealthEconomics www.rimpacts.com/rd/p?c=10041... 📄DOI: doi.org/10.1186/s129...
Give it a try, and let us know how it works for you!
Link in Bio👉️
#breastCancer #cancerFighter #breastCancerHerosJourney #breastCancerJourney #breastCancerSupport #cancerTreatment #emotionalSupport #positiveMindset #confidence #resilience #healingAndRecovery bsky.app/profile/grac...
Link in Bio👉️
#breastCancer #cancerFighter #breastCancerHerosJourney #breastCancerJourney #breastCancerSupport #cancerTreatment #emotionalSupport #positiveMindset #confidence #resilience #healingAndRecovery bsky.app/profile/grac...
Hi there, fellow breast cancer fighters! Are you feeling overwhelmed and uncertain about your journey? We understand how you feel, and that's why we're excited to introduce the Breast Cancer Hero's Journey Journal Journal!
February 17, 2026 at 1:01 AM
Give it a try, and let us know how it works for you!
Link in Bio👉️
#breastCancer #cancerFighter #breastCancerHerosJourney #breastCancerJourney #breastCancerSupport #cancerTreatment #emotionalSupport #positiveMindset #confidence #resilience #healingAndRecovery bsky.app/profile/grac...
Link in Bio👉️
#breastCancer #cancerFighter #breastCancerHerosJourney #breastCancerJourney #breastCancerSupport #cancerTreatment #emotionalSupport #positiveMindset #confidence #resilience #healingAndRecovery bsky.app/profile/grac...